BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[Option Update: Dendreon and Savient Pharma volatility elevated]]>http://www.bloggingstocks.com/2008/08/22/option-update-dendreon-and-savient-pharma-volatility-elevated/http://www.bloggingstocks.com/2008/08/22/option-update-dendreon-and-savient-pharma-volatility-elevated/http://www.bloggingstocks.com/2008/08/22/option-update-dendreon-and-savient-pharma-volatility-elevated/#commentsFiled under:

Dendreon (NASDAQ: DNDN) expects the Independent Data Monitoring Committee (IDMC) to review in October 2008 the interim analysis of overall survival relating to the Company's Phase 3 IMPACT (Immunotherapy for Prostate AdenoCarcinoma Treatment). DNDN November call option implied volatility is at 164, puts are at 195; above its 26-week average of 129 according to Track Data, suggesting larger price fluctuations.

Savient Pharma (NASDAQ: SVNT) closed at $21.95 Thursday. SVNT's Puricase (treatment for refractory gout) BLA (biologics license application) filing is expected this autumn. SVNT September and October option implied volatility is at 86, December is at 82. SVNT average option implied volatility over the last 26-weeks is 79 according to Track Data, suggesting larger price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Option Update: Dendreon and Savient Pharma volatility elevated originally appeared on BloggingStocks on Fri, 22 Aug 2008 08:33:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>dendreondndnoption implied volatilityOptionImpliedVolatilitysavient pharmaSavientPharmasvntFri, 22 Aug 2008 08:33:00 EST